scholarly journals Problem drug use the public health imperative: what some of the literature says

Author(s):  
Gez Bevan
2019 ◽  
Vol 29 (Supplement_4) ◽  
Author(s):  

Abstract According to the latest data, in 2018 about 590,000 people were held in prison on any given day in the EU, and more than double in the entire region. People in prison face multiple and complex health care issues, including a higher prevalence of communicable diseases than the general population. These are likely to be the result of a combination of overlapping, and sometimes interlinked, risk factors for infection, ill-health, and incarceration, such as problem drug use. Incarceration may facilitate the offer of quality health care services to people who are otherwise hard to reach and provide an occasion to target socially deprived groups who often have low level of healthcare access when in the community. Delivering health protection and harm reduction programmes in prisons not only benefits the prison population but also has the potential to reduce the risk of transmission of some infectious diseases in the community, intervening earlier in the natural history of disease. They are also likely also to have a knock-on effect in supporting individuals’ reintegration into community life and future health - providing a ‘community dividend’ to health interventions in prisons. Yet, such health gains may be diminished by suboptimal integration with community services. Continuity of care, or throughcare, between prison and community services is a mainstay of any health care interventions delivered in detention, especially when tackling chronic conditions (e.g. HIV, mental illnesses) or problem drug use. The World Health Organization (WHO) has long supported the concept of prison health as an inseparable component of public health. This view is enshrined by the principle of Equivalence of Care between prison and community, endorsed by the United Nations in the Nelson Mandela Rules. During the 2019 WHO Prison Health Conference in Helsinki, it was acknowledged that prisons contribute to achieving the UN’s Sustainable Development Goals through improving health, reducing health inequalities and provide a fairer and safer society for all. However, a number of challenges hampers the successful implementation of such a concept, including the need for evidence-based decision making, inter-sectoral partnerships and adequate monitoring systems. This workshop will provide attendees with a comprehensive overview of prison health and the relevance of a multi-sectorial public health approach to frame and address it. The workshop will be structured around three main topics: governance of prison health and current models in Europe; health issues and disease burden in the prison population; current and future perspectives for evidence-based approaches to prison health. The discussion of two case studies, problem drug use and HCV micro-elimination, will create the context for an in-depth analysis of key challenges for prison health implementation, reflecting on aspects such as health needs, equity, multidisciplinarity, continuity of care, monitoring and community dividend. Key messages Provide a comprehensive picture of the main challenges of prison health in Europe, the public health issues affecting the prison population and how these relate to community public health systems. Reflect on how public health systems need to incorporate prison health into their strategies for reducing inequalities and improving health outcomes of vulnerable and socially deprived populations.


2009 ◽  
Vol 14 (9) ◽  
Author(s):  
V A Gyarmathy ◽  
I Giraudon ◽  
D Hedrich ◽  
L Montanari ◽  
B Guarita ◽  
...  

Problem drug use in pregnancy affects a sizeable population in Europe. A literature review was carried out of articles in PubMed, European Monitoring Centre for Drugs and Drug Addiction publications, and related documents in order to assess public health challenges and possible intervention strategies related to problem drug use and pregnancy in Europe. It revealed the following: Involving pregnant drug users in drug treatment is likely to decrease the chances of pre- and perinatal complications related to drug use and to increase access to prenatal care. Timely medical intervention can effectively prevent vertical transmission of human immunodeficiency virus, hepatitis B virus as well as certain other sexually transmitted diseases, and would allow newborns infected with hepatitis C virus during birth to receive immediate treatment. Pregnancy may be a unique opportunity to also help women with dual diagnosis (substance use combined with mental illness) and enrol them into special treatment and support programmes. Issues related to homelessness and intimate partner violence can also be addressed with appropriate interventions. Treatment and care for pregnant drug users should offer coordinated interventions in several areas: drug use, infectious diseases, mental health, personal and social welfare, and gynaecological/obstetric care.


2010 ◽  
Vol 18 (1) ◽  
pp. 3-9 ◽  
Author(s):  
Joanne Neale ◽  
Sarah Nettleton ◽  
Lucy Pickering

Sign in / Sign up

Export Citation Format

Share Document